Medifast, Inc. is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins. The Company provides weight loss, weight management and healthy living products and programs through multiple channels of distribution, which include Take Shape For Life; its direct to consumer business unit through its Website and in-house call centers; Franchise Medifast Weight Control Centers, and a national network of physicians. The Company offers a range of weight loss, weight management and healthy products under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape For Life, Flavors of Home and Essential 1 brands. The Company also offers a sports nutrition pilot product line, Dual Fuel.
Industry, Sector and Symbol:
- Sector: Consumer Staples
- Industry: Special Foods & Welbeing Products
- Sub-Industry: Personal Products
- Symbol: NYSE:MED
- CUSIP: 58470H10
- Web: www.medifast1.com
Capitalization:- Market Cap: $686.22 million
- Outstanding Shares: 11,930,000
Average Prices:- 50 Day Moving Avg: $52.60
- 200 Day Moving Avg: $45.49
- 52 Week Range: $36.70 - $58.64
P/E:- Trailing P/E Ratio: 28.23
- Foreward P/E Ratio: 23.01
- P/E Growth: 1.78
Sales & Book Value:- Annual Revenue: $277.4 million
- Price / Sales: 2.47
- Book Value: $8.73 per share
- Price / Book: 6.59
Dividend:- Annual Dividend: $1.28
- Dividend Yield: 2.2%
Profitability:- EBIDTA: $40.01 million
- Net Margins: 8.62%
- Return on Equity: 24.25%
- Return on Assets: 19.24%
Debt:- Current Ratio: 4.40%
- Quick Ratio: 3.69%
Misc:- Average Volume: 105,117 shs.
- Beta: 0.43
- Short Ratio: 0.17
Frequently Asked Questions for Medifast (NYSE:MED)
What is Medifast's stock symbol?
Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."
How often does Medifast pay dividends? What is the dividend yield for Medifast?
Medifast declared a quarterly dividend on Thursday, September 7th. Investors of record on Friday, September 22nd will be given a dividend of $0.32 per share on Thursday, November 9th. This represents a $1.28 annualized dividend and a yield of 2.23%. The ex-dividend date is Thursday, September 21st. View Medifast's Dividend History.
How were Medifast's earnings last quarter?
Medifast Inc (NYSE:MED) issued its quarterly earnings data on Tuesday, August, 8th. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.10. The firm earned $75.70 million during the quarter, compared to analysts' expectations of $71.96 million. Medifast had a return on equity of 24.25% and a net margin of 8.62%. Medifast's quarterly revenue was up 6.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.63 earnings per share. View Medifast's Earnings History.
When will Medifast make its next earnings announcement?
What guidance has Medifast issued on next quarter's earnings?
Medifast updated its FY17 earnings guidance on Tuesday, August, 8th. The company provided earnings per share (EPS) guidance of $2.05-$2.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.02. The company issued revenue guidance of $290-$300 million, compared to the consensus revenue estimate of $288.65 million.Medifast also updated its Q3 guidance to $0.48-$0.51 EPS.
Where is Medifast's stock going? Where will Medifast's stock price be in 2017?
2 brokerages have issued twelve-month price objectives for Medifast's shares. Their forecasts range from $55.00 to $74.00. On average, they expect Medifast's share price to reach $64.50 in the next year. View Analyst Ratings for Medifast.
Who are some of Medifast's key competitors?
Some companies that are related to Medifast include Scholastic Corporation (SCHL), Time (TIME), Calavo Growers (CVGW), Inter Parfums (IPAR), Adecoagro S.A. (AGRO), Avon Products (AVP), Dean Foods Company (DF), MGP Ingredients (MGPI), Revlon (REV), Cresud S.A.C.I.F. y A. (CRESY), Gannett Co. (GCI), e.l.f. Beauty (ELF), SuperValu (SVU), New Media Investment Group (NEWM), SunOpta (STKL), Smart (SFS), Amplify Snack Brands, inc. (BETR) and The Chefs' Warehouse (CHEF).
Who are Medifast's key executives?
Medifast's management team includes the folowing people:
- Michael Charles MacDonald, Executive Chairman of the Board
- Daniel R. Chard, Chief Executive Officer, Director
- Timothy G. Robinson CPA, Chief Financial Officer
- Jason L. Groves Esq., Executive Vice President, General Counsel
- Joseph P. Kelleman, Vice President - Finance, CorporateController
- Kevin G. Byrnes, Independent Director
- Charles P. Connolly, Independent Director
- Carl E. Sassano, Independent Director
Who owns Medifast stock?
Medifast's stock is owned by many different of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (8.02%), Dimensional Fund Advisors LP (5.53%), Vanguard Group Inc. (5.51%), Acadian Asset Management LLC (3.91%), Kennedy Capital Management Inc. (3.34%) and State Street Corp (2.70%). Company insiders that own Medifast stock include Balanced Master Fund L Visium, Glenn W Welling, Jeffrey J Brown and Margaret Sheetz. View Institutional Ownership Trends for Medifast.
Who sold Medifast stock? Who is selling Medifast stock?
Medifast's stock was sold by a variety of institutional investors in the last quarter, including Numeric Investors LLC, GSA Capital Partners LLP, Menta Capital LLC, TIAA CREF Investment Management LLC, Wells Fargo & Company MN, Russell Investments Group Ltd., First Quadrant L P CA and Prudential Financial Inc.. View Insider Buying and Selling for Medifast.
Who bought Medifast stock? Who is buying Medifast stock?
Medifast's stock was bought by a variety of institutional investors in the last quarter, including Marshall Wace North America L.P., Goldman Sachs Group Inc., American Century Companies Inc., Citadel Advisors LLC, Schroder Investment Management Group, Dimensional Fund Advisors LP, Dean Capital Management and LSV Asset Management. Company insiders that have bought Medifast stock in the last two years include Glenn W Welling and Jeffrey J Brown. View Insider Buying and Selling for Medifast.
How do I buy Medifast stock?
Shares of Medifast can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Medifast's stock price today?
One share of Medifast stock can currently be purchased for approximately $57.52.
MarketBeat Community Rating for Medifast (NYSE MED)MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Medifast (NYSE:MED) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Hold Rating, 1 Buy Rating |
| Consensus Rating: | Buy (Score: 2.50) |
| Consensus Price Target: | $64.50 (12.13% upside) |
Analysts' Ratings History for Medifast (NYSE:MED)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/21/2017 | Sidoti | Reiterated Rating | Neutral | $49.00 -> $55.00 | Low |  |
| 9/15/2017 | DA Davidson | Boost Price Target | Buy -> Buy | $65.00 -> $74.00 | High | |
| 8/4/2016 | Wunderlich | Boost Price Target | Hold | $32.00 -> $36.00 | N/A | |
| 11/8/2015 | Canaccord Genuity | Reiterated Rating | Hold | $33.00 | N/A | |
(Data available from 9/22/2015 forward)
Earnings History for Medifast (NYSE:MED)Earnings History by Quarter for Medifast (NYSE MED)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/2/2017 | | | | | | | | |
| 8/8/2017 | Q2 2017 | $0.53 | $0.63 | $71.96 million | $75.70 million | View | Listen | |
| 5/4/2017 | Q1 2017 | $0.49 | $0.51 | $72.36 million | $70.62 million | View | Listen | |
| 3/9/2017 | Q4 2016 | $0.33 | $0.34 | $65.01 million | $62.50 million | View | Listen | |
| 11/3/2016 | Q316 | $0.45 | $0.51 | $66.79 million | $68.57 million | View | N/A | |
| 8/3/2016 | Q216 | $0.51 | $0.63 | $72.01 million | $71.14 million | View | N/A | |
| 5/4/2016 | Q116 | $0.33 | $0.42 | $69.31 million | $72.30 million | View | N/A | |
| 3/10/2016 | Q415 | $0.35 | $0.33 | $62.98 million | $61.30 million | View | Listen | |
| 11/5/2015 | Q315 | $0.42 | $0.45 | $67.00 million | $65.90 million | View | N/A | |
| 8/5/2015 | Q215 | $0.48 | $0.48 | $72.79 million | $72.20 million | View | N/A | |
| 5/7/2015 | Q115 | $0.35 | $0.46 | $71.80 million | $73.30 million | View | N/A | |
| 3/12/2015 | Q414 | $0.46 | $0.38 | $69.40 million | $62.30 million | View | N/A | |
| 11/5/2014 | Q314 | $0.36 | $0.47 | $76.10 million | $74.00 million | View | N/A | |
| 8/7/2014 | Q114 | $0.40 | $0.44 | $87.30 million | $80.88 million | View | N/A | |
| 5/5/2014 | Q1 | $0.37 | $0.45 | $87.60 million | $86.50 million | View | N/A | |
| 3/10/2014 | Q413 | $0.36 | $0.39 | $80.83 million | $77.30 million | View | N/A | |
| 11/5/2013 | Q313 | $0.42 | $0.41 | $95.07 million | $86.48 million | View | N/A | |
| 8/6/2013 | Q2 2013 | $0.51 | $0.51 | $101.30 million | $97.10 million | View | N/A | |
| 5/8/2013 | Q1 2013 | $0.34 | $0.43 | $93.77 million | $96.00 million | View | N/A | |
| 3/7/2013 | Q4 2012 | $0.25 | $0.28 | $82.90 million | $83.20 million | View | N/A | |
| 11/5/2012 | Q312 | $0.40 | $0.42 | $89.73 million | $91.00 million | View | N/A | |
| 7/26/2012 | | $0.38 | $0.47 | | | View | N/A | |
| 5/8/2012 | | $0.38 | $0.29 | | | View | N/A | |
| 3/13/2012 | | $0.21 | $0.08 | | | View | N/A | |
| 11/3/2011 | | $0.38 | $0.36 | | | View | N/A | |
| 8/4/2011 | | $0.47 | $0.41 | | | View | N/A | |
| 5/9/2011 | | $0.41 | $0.44 | | | View | N/A | |
| 3/31/2011 | | $0.32 | $0.23 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Medifast (NYSE:MED)2017 EPS Consensus Estimate: $0.98
2018 EPS Consensus Estimate: $2.50
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q3 2017 | 1 | $0.51 | $0.51 | $0.51 |
| Q4 2017 | 1 | $0.47 | $0.47 | $0.47 |
| Q1 2018 | 1 | $0.58 | $0.58 | $0.58 |
| Q2 2018 | 1 | $0.74 | $0.74 | $0.74 |
| Q3 2018 | 1 | $0.61 | $0.61 | $0.61 |
| Q4 2018 | 1 | $0.57 | $0.57 | $0.57 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Medifast (NYSE:MED)| Next Dividend: | 11/9/2017 |
| Annual Dividend: | $1.28 |
| Dividend Yield: | 2.23% |
| Dividend Growth: | 0.00% (3 Year Average) |
| Payout Ratio: | 64.32% (Trailing 12 Months of Earnings)
60.38% (Based on This Year's Estimates)
51.20% (Based on Next Year's Estimates)
|
Dividend History by Quarter for Medifast (NYSE MED)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 9/7/2017 | quarterly | $0.32 | 2.31% | 9/21/2017 | 9/22/2017 | 11/9/2017 |
| 6/7/2017 | Quarterly | $0.32 | 3.1% | 6/21/2017 | 6/23/2017 | 8/9/2017 |
| 3/8/2017 | quarterly | $0.32 | 2.92% | 3/21/2017 | 3/23/2017 | 5/9/2017 |
| 12/9/2016 | quarterly | $0.32 | 3.13% | 12/21/2016 | 12/23/2016 | 2/9/2017 |
| 9/9/2016 | quarterly | $0.25 | 2.75% | 9/21/2016 | 9/23/2016 | 11/10/2016 |
| 6/16/2016 | quarterly | $0.25 | 3.04% | 6/23/2016 | 6/27/2016 | 8/10/2016 |
| 3/10/2016 | quarterly | $0.25 | 3.25% | 3/17/2016 | 3/21/2016 | 5/10/2016 |
| 12/16/2015 | special | $0.25 | | 12/23/2015 | 12/28/2015 | 2/10/2016 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Medifast (NYSE:MED)Insider Ownership Percentage: 6.47%
Institutional Ownership Percentage: 89.48%
Insider Trades by Quarter for Medifast (NYSE:MED)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 3/14/2017 | Glenn W Welling | Director | Buy | 17,084 | $41.33 | $706,081.72 | |
| 11/15/2016 | Glenn W Welling | Director | Buy | 35,000 | $39.02 | $1,365,700.00 | |
| 11/9/2016 | Jeffrey J Brown | Director | Buy | 10,000 | $38.71 | $387,100.00 | |
| 5/31/2016 | Balanced Master Fund L Visium | Major Shareholder | Sell | 1,350,000 | $30.25 | $40,837,500.00 | |
| 4/1/2016 | Margaret Sheetz | COO | Sell | 8,333 | $30.02 | $250,156.66 | |
| 2/1/2016 | Margaret Sheetz | COO | Sell | 8,333 | $28.62 | $238,490.46 | |
| 12/1/2015 | Margaret Sheetz | COO | Sell | 8,333 | $29.92 | $249,323.36 | |
| 11/2/2015 | Margaret Sheetz | COO | Sell | 8,333 | $28.72 | $239,323.76 | |
| 10/5/2015 | Margaret Sheetz | COO | Sell | 8,333 | $28.88 | $240,657.04 | |
| 9/3/2015 | Margaret Sheetz | COO | Sell | 6,864 | $28.00 | $192,192.00 | |
| 9/2/2015 | Margaret Sheetz | COO | Sell | 1,469 | $28.00 | $41,132.00 | |
| 6/25/2015 | Moduslink Global Solutions Inc | Major Shareholder | Sell | 29,654 | $33.03 | $979,471.62 | |
| 6/23/2015 | Moduslink Global Solutions Inc | Major Shareholder | Sell | 27,443 | $33.01 | $905,893.43 | |
| 6/22/2015 | Moduslink Global Solutions Inc | Major Shareholder | Sell | 9,494 | $33.01 | $313,396.94 | |
| 6/11/2015 | Barry B Bondroff | Director | Sell | 1,666 | $31.88 | $53,112.08 | |
| 6/10/2015 | Margaret Sheetz | COO | Sell | 8,337 | $32.00 | $266,784.00 | |
| 6/4/2015 | John P Mcdaniel | Director | Sell | 3,000 | $32.14 | $96,420.00 | |
| 8/18/2014 | Jeannette M Mills | EVP | Sell | 3,000 | $28.03 | $84,090.00 | |
| 6/10/2014 | Jason L Groves | EVP | Sell | 3,250 | $31.75 | $103,187.50 | |
| 6/10/2014 | John P Mcdaniel | Director | Sell | 3,500 | $31.74 | $111,090.00 | |
| 6/9/2014 | Jeannette M Mills | EVP | Sell | 2,784 | $32.09 | $89,338.56 | |
| 6/5/2014 | Charles P Connolly | Director | Sell | 7,500 | $30.91 | $231,825.00 | |
| 12/2/2013 | Margaret Macdonald Sheetz | COO | Sell | 18,000 | $25.63 | $461,340.00 | |
| 11/22/2013 | Margaret Macdonald Sheetz | COO | Sell | 35,000 | $24.33 | $851,550.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Medifast (NYSE:MED)
Latest Headlines for Medifast (NYSE:MED)
| Source: |
|
| Date | Headline |
|---|
 | Sidoti Reiterates Neutral Rating for Medifast Inc (MED)
www.americanbankingnews.com - September 21 at 6:58 PM |
 | ETFs with exposure to Medifast, Inc. : September 19, 2017
finance.yahoo.com - September 20 at 6:16 AM |
| Medifast® Announces New Corporate Headquarters in Baltimore City
finance.yahoo.com - September 18 at 9:16 PM |
| Medifast confirms headquarters move to Harbor East
finance.yahoo.com - September 18 at 9:16 PM |
| Medifast, Inc. :MED-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 18 at 9:16 PM |
| DA Davidson Comments on Medifast Inc's FY2019 Earnings (MED)
www.americanbankingnews.com - September 18 at 9:06 AM |
| Medifast Inc (MED) Price Target Raised to $74.00 at DA Davidson
www.americanbankingnews.com - September 15 at 8:00 PM |
| Medifast Inc Plans Quarterly Dividend of $0.32 (MED)
www.americanbankingnews.com - September 7 at 5:28 PM |
| MEDIFAST INC (MED) Forecasted to Earn Q3 2017 Earnings of $0.51 Per Share
www.americanbankingnews.com - August 21 at 2:52 AM |
| Medifast Inc (MED) Raised to "Hold" at BidaskClub
www.americanbankingnews.com - August 19 at 4:38 PM |
 | Bloomberg Markets: Dave Wilson’s Stock of the Day for Aug. 17
www.bloomberg.com - August 18 at 6:42 AM |
| Stock Indexes Retreat Fast; Medifast Thrusts Higher
finance.yahoo.com - August 18 at 6:42 AM |
| Medifast, Inc. – Value Analysis (NYSE:MED) : August 17, 2017
finance.yahoo.com - August 17 at 2:33 AM |
| Medifast Inc (MED) Now Covered by Analysts at DA Davidson
www.americanbankingnews.com - August 16 at 5:40 PM |
| Medifast Inc (MED) Upgraded at BidaskClub
www.americanbankingnews.com - August 13 at 9:02 AM |
| Medifast stock skyrockets 13 percent to $50 per share after earnings beat Wall Street estimates
finance.yahoo.com - August 11 at 6:28 AM |
| Medifast, Inc.: Gathering momentum, can it sustain its performance?
finance.yahoo.com - August 11 at 6:28 AM |
| Edited Transcript of MED earnings conference call or presentation 8-Aug-17 8:30pm GMT
finance.yahoo.com - August 10 at 5:02 AM |
 | Medifast's (MED) CEO Daniel Chard on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 11:31 PM |
| Investor Network: Medifast, Inc. to Host Earnings Call
finance.yahoo.com - August 8 at 11:31 PM |
| Medifast, Inc. Announces Second Quarter 2017 Financial Results
finance.yahoo.com - August 8 at 11:31 PM |
| Medifast posts 2Q profit
finance.yahoo.com - August 8 at 11:31 PM |
| MEDIFAST INC (MED) Posts Earnings Results, Beats Estimates By $0.11 EPS
www.americanbankingnews.com - August 8 at 6:30 PM |
| MEDIFAST INC (NYSE:MED) Issues Q3 Earnings Guidance
www.americanbankingnews.com - August 8 at 5:38 PM |
| MEDIFAST INC (MED) Updates FY17 Earnings Guidance
www.americanbankingnews.com - August 8 at 5:38 PM |
| Medifast, Inc. breached its 50 day moving average in a Bearish Manner : MED-US : August 4, 2017
finance.yahoo.com - August 5 at 2:45 AM |
| MEDIFAST INC (NYSE:MED) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - August 1 at 9:39 AM |
 | Global Weight Loss and Diet Management Market - Industry Forecast to 2025 - Huge Growth Potential from Developing Economies
www.finanznachrichten.de - July 25 at 11:55 PM |
| Take Shape For Life® Rebrands to OPTAVIA™
finance.yahoo.com - July 24 at 1:35 PM |
 | When it comes to CEO pay, performance matters
www.bizjournals.com - July 23 at 5:17 AM |
| MEDIFAST INC (NYSE:MED) vs. Nutraceutical International Corporation (NUTR) Financial Review
www.americanbankingnews.com - July 20 at 5:21 PM |
| Medifast, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2017
finance.yahoo.com - July 18 at 11:18 PM |
| MEDIFAST INC (NYSE:MED) & Nutraceutical International Corporation (NUTR) Head to Head Analysis
www.americanbankingnews.com - July 17 at 9:54 AM |
| Head to Head Analysis: Nutraceutical International Corporation (NUTR) vs. MEDIFAST INC (MED)
www.americanbankingnews.com - July 14 at 8:50 AM |
| Financial Analysis: MEDIFAST INC (NYSE:MED) & Nutraceutical International Corporation (NUTR)
www.americanbankingnews.com - July 8 at 8:24 AM |
| ETFs with exposure to Medifast, Inc. : July 6, 2017
finance.yahoo.com - July 7 at 7:22 AM |
| Comparing MEDIFAST INC (NYSE:MED) and Nutraceutical International Corporation (NUTR)
www.americanbankingnews.com - July 6 at 7:42 AM |
| Comparing Nutraceutical International Corporation (NUTR) and Medifast (MED)
www.americanbankingnews.com - July 4 at 12:14 AM |
| Brokerages Expect Medifast Inc (MED) to Post $0.53 EPS
www.americanbankingnews.com - June 28 at 12:30 AM |
| MEDIFAST INC (MED) vs. Nutraceutical International Corporation (NUTR) Head to Head Review
www.americanbankingnews.com - June 27 at 6:22 PM |
| Medifast, Inc. : MED-US: Dividend Analysis : June 23rd, 2017 (record date) : By the numbers : June 21, 2017
finance.yahoo.com - June 21 at 7:39 PM |
| Medifast, Inc. :MED-US: Earnings Analysis: Q1, 2017 By the Numbers : June 21, 2017
finance.yahoo.com - June 21 at 7:39 PM |
| Take Shape For Life® Named to 2017 Direct Selling Association Top 20 List
finance.yahoo.com - June 20 at 7:30 PM |
| Dividend Coverage: This Nutrition and Weight Loss Company has a Dividend Yield of 3.02%; Will Trade Ex-Dividend on June 21, 2017
finance.yahoo.com - June 20 at 7:30 PM |
| MEDIFAST INC Declares Quarterly Dividend of $0.32 (MED)
www.americanbankingnews.com - June 16 at 1:22 PM |
 | BRIEF-Medifast Inc may repurchase up to 850,000 shares of common stock
www.reuters.com - June 15 at 2:56 AM |
| Medifast® Announces 10b5-1 Plan to Facilitate Continued Share Repurchases
finance.yahoo.com - June 14 at 9:36 AM |
| Exclusive: Medifast explores move from Baltimore County to Harbor East
www.bizjournals.com - June 7 at 6:08 PM |
| Medifast Inc (MED) Expected to Post Earnings of $0.53 Per Share
www.americanbankingnews.com - June 1 at 8:20 PM |
| 5 Must See Earnings Charts
finance.yahoo.com - May 24 at 10:51 AM |
Medifast (MED) Chart for Friday, September, 22, 2017
